A fraction of patients have shown intellectual disability or ASD without epilepsy (3%).2 Recent GAT1 analyses support complete or partial loss-of-function (LoF) as the primary disease-associated molecular pathology, which disrupts the reuptake of GABA.5-9. This evidence concerns the gene SLC6A1 and Intellectual disability.